Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.

Pr Eric RenardNadia Tubiana-RufiElisabeth BonnemaisonRégis CoutantFabienne Dalla-ValeElise BismuthNathalie FaureNatacha Bouhours-NouetAnne FarretCaroline StoreyAurélie DonzeauAmélie PoidvinJessica Amsellem-JagerJérôme PlaceMarc D Bretonnull null

Published in: Diabetes, obesity & metabolism (2021)

The current study shows the safety and efficacy of the Tandem Control-IQ system in free-living children with type 1 diabetes for both E/N and 24/7 use; 24/7 use shows better outcomes, sustained for up to 36 weeks with no safety issues.

Keyphrases

young adults
type diabetes
clinical trial
glycemic control
double blind
study protocol
randomized controlled trial
cross sectional
metabolic syndrome
depressive symptoms
adipose tissue
skeletal muscle
insulin resistance
weight loss
growth hormone